92 related articles for article (PubMed ID: 8238446)
1. The effect of pregnancy on the response to the TxA2/PGH2 analogue U-46619 in rabbits.
Losonczy G; Mucha I; DiPirro J; Sweeney J; Brown G; Brentjens J; Venuto R
Am J Physiol; 1993 Oct; 265(4 Pt 2):R772-80. PubMed ID: 8238446
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy enhances the pressor response to thromboxane analogues in rabbits.
Losonczy G; Singh JP; Schoenl M; Mucha I; Venuto RC
Am J Physiol; 1995 Sep; 269(3 Pt 2):R720-5. PubMed ID: 7573575
[TBL] [Abstract][Full Text] [Related]
3. Gestational resistance to the pulmonary vasoconstrictor effect of the TxA2 mimetic U-46619: possible mechanism.
Losonczy G; Brown G; Mucha I; Klocke R; Muller V; Merkely B; Tornoci L; Rosivall L; Venuto R
Am J Physiol; 1997 Jun; 272(6 Pt 2):R1734-9. PubMed ID: 9227584
[TBL] [Abstract][Full Text] [Related]
4. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
5. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
6. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
7. In vivo effects of a novel thromboxane A2/prostaglandin H2 (TXA2/PGH2) partial agonist, (+)5(Z)-7-[3-endo-phenylsulfonylamino[2.2.1]- bicyclohept-2-exo-yl]-heptenoic acid [(+)-S-145], on vascular, platelet and cardiac function.
Dubé GP; Jakubowski JA; Brune KA; Bemis KG; Kurtz WL
J Pharmacol Exp Ther; 1995 Feb; 272(2):799-807. PubMed ID: 7853197
[TBL] [Abstract][Full Text] [Related]
8. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
Okwu AK; Ullian ME; Halushka PV
J Pharmacol Exp Ther; 1992 Jul; 262(1):238-45. PubMed ID: 1378092
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist.
Morinelli TA; Oatis JE; Okwu AK; Mais DE; Mayeux PR; Masuda A; Knapp DR; Halushka PV
J Pharmacol Exp Ther; 1989 Nov; 251(2):557-62. PubMed ID: 2530338
[TBL] [Abstract][Full Text] [Related]
10. Platelet endoperoxide/thromboxane A2 (PGH2/TXA2) receptors in patients with myeloproliferative disorders.
Faul C; Renn W; Jaschonek K
Prostaglandins Leukot Essent Fatty Acids; 1991 Aug; 43(4):273-6. PubMed ID: 1835097
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo.
Bertolino F; Valentin JP; Maffre M; Grelac F; Bessac AM; Maclouf J; Delhon A; Lévy-Toledano S; Patoiseau JF; Colpaert FC
Br J Pharmacol; 1995 May; 115(1):210-6. PubMed ID: 7647979
[TBL] [Abstract][Full Text] [Related]
12. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP.
Morinelli TA; Naka M; Masuda A; Oatis JE; Okwu AK; Mais DE; Saussy DL; Halushka PV
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():331-7. PubMed ID: 1825565
[No Abstract] [Full Text] [Related]
13. Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.
Dorn GW
J Clin Invest; 1989 Dec; 84(6):1883-91. PubMed ID: 2531760
[TBL] [Abstract][Full Text] [Related]
14. Human platelet aggregation and shape change are coupled to separate thromboxane A2-prostaglandin H2 receptors.
Dorn GW; DeJesus A
Am J Physiol; 1991 Feb; 260(2 Pt 2):H327-34. PubMed ID: 1825455
[TBL] [Abstract][Full Text] [Related]
15. Effect of specific phospholipid molecular species incorporated in human platelet membranes on thromboxane A2/prostaglandin H2 receptors.
Bayon Y; Croset M; Daveloose D; Guerbette F; Chirouze V; Viret J; Kader JC; Lagarde M
J Lipid Res; 1995 Jan; 36(1):47-56. PubMed ID: 7706947
[TBL] [Abstract][Full Text] [Related]
16. Antiaggregatory effects of thromboxane receptor antagonists in vivo.
Darius H; Lefer AM
Thromb Res; 1985 Dec; 40(5):663-75. PubMed ID: 2935972
[TBL] [Abstract][Full Text] [Related]
17. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological evidence for thromboxane receptor heterogeneity--implications for the eye.
Krauss AH; Woodward DF; Burk RM; Gac TS; Gibson LL; Protzman CE; Abbass F; Marshall K; Senior J
J Ocul Pharmacol Ther; 1997 Aug; 13(4):303-12. PubMed ID: 9261766
[TBL] [Abstract][Full Text] [Related]
19. Modification on ligand binding to TXA2/PGH2 receptors by diethylpyrocarbonate.
Schrör K; Davis-Bruno K; Halushka PV
Adv Exp Med Biol; 1997; 400A():235-40. PubMed ID: 9547563
[No Abstract] [Full Text] [Related]
20. Central thromboxane receptors: mRNA expression and mediation of pressor responses.
Gao H; Peng B; Welch WJ; Wilcox CS
Am J Physiol; 1997 May; 272(5 Pt 2):R1493-500. PubMed ID: 9176341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
